SINOVAC BIOTECH LTD (SVA) Gross margin 2016–2025
SINOVAC BIOTECH LTD (SVA) gross margin by fiscal year — reported gross profit divided by reported revenue.
67.9%FY2025 · since FY2016: 69.1% → 67.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 67.9% | +6.8 pp |
| FY2024 | 61.1% | -7.7 pp |
| FY2023 | 68.8% | +13.4 pp |
| FY2022 | 55.3% | -39.6 pp |
| FY2021 | 94.9% | +8.0 pp |
| FY2020 | 86.8% | +0.0 pp |
| FY2019 | 86.8% | -2.4 pp |
| FY2018 | 89.2% | +0.8 pp |
| FY2017 | 88.4% | +19.3 pp |
| FY2016 | 69.1% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice